Moderna
MRNA
$132.50
Share price
2.67%
Change (1 day)
1.72%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Earnings for Moderna (MRNA)
Earnings in 2023 (TTM): -$3.91 B
According to Moderna 's latest financial reports the company's current earnings (TTM) are -$4.77 B. In 2022 the company made an earning of $9.60 B a decrease over its 2021 earnings that were of $13.30 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Moderna from 2018 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$3.91 B | -140.65% |
| 2022 | $9.60 B | -27.81% |
| 2021 | $13.30 B | -1911.15% |
| 2020 | -$0.74 B | 44.7% |
| 2019 | -$0.51 B | 28.63% |
| 2018 | -$0.4 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -548.14% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -306.15% | 🇨🇭 Switzerland |
 Merck MRK | $3.03 B | -163.67% | 🇺🇸 USA |
 Regulus Therapeutics RGLS | -$29.44 M | -99.38% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | -$0.12 B | -97.53% | 🇺🇸 USA |
 Athersys ATHX | -$41.77 M | -99.12% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.2 B | -95.86% | 🇺🇸 USA |
 Arrowhead Pharmaceuticals
ARWR | -$0.29 B | -94.07% | 🇺🇸 USA |